search again

Nationwide rates for HCPCS M0250

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose

Facilitymedian $447 · 10th–90th $417$1,2020%50%10th90th$447Professionalmedian $447 · 10th–90th $447$5010%50%90th$447$5.0$50.0$500.0$5.0K$50.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$446.68 / $446.68 / $537.03
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$446.68 / $446.68 / $446.68
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562.34 / $933.25 / $5,011.87
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$363.08 / $446.68 / $1,000.00
Cigna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$446.68 / $446.68 / $562.34
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$398.11 / $446.68 / $562.34
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$416.87 / $512.86 / $1,548.82
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$407.38 / $588.84 / $1,047.13